header

Browse our Calendar!

Mon Tue Wed Thu Fri Sat Sun
1
Date : Saturday, 01 December 2018
2
3
Date : Monday, 03 December 2018
4
Date : Tuesday, 04 December 2018
5
Date : Wednesday, 05 December 2018
6
Date : Thursday, 06 December 2018
7
Date : Friday, 07 December 2018
8
9
15
16
17
21
22
23
24
25
27
28
29
30
31

Joint EFGCP & DIA Better Medicines for Children Conference: From development to access

Category
Health
Date
Thursday, 25 October 2018 08:00 - 16:00
Venue
The Hotel - Boulevard de Waterloo 38, 1000 Bruxelles
Telephone
+32 27328783
Email
This email address is being protected from spambots. You need JavaScript enabled to view it.
Website

This conference is a yearly event organised by the EFGCP Children Medicines Working Party in collaboration with DIA and Regulators to take stock of the progress achieved in the paediatric field after 10 years of Paediatric Regulation and, to move the discussion forward. It provides a unique multi-stakeholder platform to share and discuss important and challenging topics related to the development of paediatric medicines.

 

This year’s conference focuses on what could be done to optimise children’s access to new medicines. “Access” can be broadly defined as

1) inclusion of paediatric patients into clinical trials,

2) Health authority approval of a new medicine and,

3) children’s access to a medicine that has been approved by regulators.

 

After keynotes by Francoise Grossetête (MEP) and Andrzej Rys (European Commission), we will hear from various stakeholders what is currently done to enhance children’s access to medicines and how stakeholders are working together. Interactive breakout sessions will allow all participants to actively engage in the discussion to identify innovative solutions to address access issues specific to paediatric subpopulations, such as adolescents, or neonates.

A Q&A session with members of the EMA Paediatric committee (PDCO), moderated by Dr Dirk Mentzer (PDCO chair) will help understand PDCO specific activities and priorities, and address questions from the audience. A panel discussion by patients and parents will highlight the priorities from a societal perspective and enable participants to reflect on the goals of paediatric research activities. Stakeholders recognize that more treatment access can be achieved by accelerating development of new medicines.

Current delays in clinical trial conduct relating to recruitment difficulties will be addressed, e.g. by optimising the number of children needed for clinical trials, or recruitment strategies. Information on constructive multi-stakeholder collaborations, which were set up to address the perceived long-term gaps will be provided; an opportunity to understand further what could help foster paediatric development and children’s access to new medicines.

The conference will end with a panel discussion to explore what needs to be further achieved to meet the goal, which is to increase children’s access to new treatments.

 
 

All Dates

  • From Thursday, 25 October 2018 08:00 to Friday, 26 October 2018 16:00
    Thursday & Friday

Powered by iCagenda